Understanding antibiotic misuse in Kazakhstan: insights from the WHO behavioral survey on COVID-19

Serzhan Nazarbek1,2, Nurzhan Aidossov3, Ane Tynyshbayeva4

  • 1Club of Experts under the Senate of the Republic of Kazakhstan, Astana, Kazakhstan.

BMC Infectious Diseases
|October 16, 2025
PubMed
Abstract

Insights

Non-prescription antibiotic use in Kazakhstan was linked to rural residency and COVID-19 perceptions. Lower trust in healthcare professionals correlated with misuse, despite self-medicators adhering to preventive measures.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • Antimicrobial resistance (AMR) is a significant global health threat, worsened by antibiotic misuse, especially during the COVID-19 pandemic.
  • Self-medication with antibiotics is prevalent in low- and middle-income countries, posing challenges to effective AMR containment.

Purpose of the Study:

  • To investigate the prevalence of non-prescription antibiotic use in Kazakhstan during the COVID-19 pandemic.
  • To identify socio-demographic factors and behavioral drivers associated with antibiotic misuse.

Main Methods:

  • A cross-sectional online survey was conducted among adults in Kazakhstan.
  • The survey utilized a snowball sampling technique and adapted the WHO Europe behavioral insights tool.

Main Results:

  • Non-prescription antibiotic use was higher among rural residents and caregivers of children, and associated with high perceived COVID-19 probability and severity.
  • Low trust in healthcare professionals was significantly linked to antibiotic misuse.
  • Individuals misusing antibiotics showed higher adherence to preventive measures like handwashing and mask-wearing.

Conclusions:

  • Targeted public health strategies are crucial to address healthcare access disparities and enhance antibiotic stewardship.
  • Building trust in medical professionals is essential for mitigating AMR risks in Kazakhstan.
  • Understanding behavioral drivers of antibiotic misuse is key to developing effective interventions.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...